Little T, US$55m wasn’t my estimate – I simply used the estimated development costs provided by NEU.
Agreed that doesn’t take into account the Fragile X trial costs, but that is because I was referring to committed expenditure. It’s been almost two years since the deal was signed with Acadia and there’s been no word yet on movement with Fragile X development. If the Phase 3 Rett trial fails, it is highly likely that Acadia won't proceed with Fragile X development, imo. It is free to terminate with 90 days' notice.
NEU Price at posting:
$1.64 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)